Clinical Cancer Research Holland
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bachmann, I. M.
Right arrow Articles by Akslen, L. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bachmann, I. M.
Right arrow Articles by Akslen, L. A.
Clinical Cancer Research Vol. 11, 8606-8614, December 15, 2005
© 2005 American Association for Cancer Research


Imaging, Diagnosis, Prognosis

Importance of P-Cadherin, ß-Catenin, and Wnt5a/Frizzled for Progression of Melanocytic Tumors and Prognosis in Cutaneous Melanoma

Ingeborg M. Bachmann, Oddbjørn Straume, Hanne E. Puntervoll, May Britt Kalvenes and Lars A. Akslen

Authors' Affiliation: The Gade Institute, Section for Pathology, University of Bergen, Bergen, Norway

Requests for reprints: Lars A. Akslen, Children's Hospital, Harvard Medical School, Vascular Biology Program, Karp Family Research Labs 12.125, 300 Longwood Avenue, Boston, MA 02115-5737. Phone: 617-919-2426; Fax: 617-739-5891; E-mail: lars.akslen{at}childrens.harvard.edu or lars.akslen{at}gades.uib.no.

Purpose: It has been proposed that melanoma cells shift from E-cadherin to N-cadherin expression during tumor development, and recent gene profiling has shown increased expression of Wnt5a/Frizzled in aggressive melanomas possibly by interactions with ß-catenin. We therefore wanted to investigate the role of cadherin subtypes, ß-catenin, and Wnt5a/Frizzled in melanocytic tumors, with focus on prognosis in nodular melanomas.

Experimental Design: The immunohistochemical expression of E-cadherin, N-cadherin, P-cadherin, ß-catenin, and Wnt5a/Frizzled was examined using tissue microarrays of 312 melanocytic tumors.

Results: Cytoplasmic expression of P-cadherin was associated with increasing tumor thickness (P = 0.005) and level of invasion (P = 0.019), whereas membranous staining was associated with thinner (P = 0.012) and more superficial (P = 0.018) tumors. Increased cytoplasmic P-cadherin was associated with reduced survival (P = 0.047). Lack of nuclear ß-catenin expression was related to increased tumor thickness (P = 0.002) and poor patient survival in univariate (P = 0.0072) and multivariate (P = 0.004) analyses. Membranous expression of N-cadherin was significantly increased from primary tumors to metastatic lesions, whereas E-cadherin staining tended to be decreased. Wnt5a and its receptor Frizzled were highly coexpressed, and nuclear expression of both markers was significantly reduced from benign nevi to melanomas, with a shift from nuclear to cytoplasmic expression in malignant tumors. In addition, Wnt5a expression was significantly associated with nuclear ß-catenin expression.

Conclusions: Alterations in the expression and subcellular localization of cell adhesion markers are important in the development and progression of melanocytic tumors, and strong cytoplasmic P-cadherin expression and loss of nuclear ß-catenin staining were associated with aggressive melanoma behavior and reduced patient survival.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
P. D. Da Forno, J. H. Pringle, P. Hutchinson, J. Osborn, Q. Huang, L. Potter, R. A. Hancox, A. Fletcher, and G. S. Saldanha
WNT5A Expression Increases during Melanoma Progression and Correlates with Outcome
Clin. Cancer Res., September 15, 2008; 14(18): 5825 - 5832.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
G. M. Kreizenbeck, A. J. Berger, A. Subtil, D. L. Rimm, and B. E. Gould Rothberg
Prognostic Significance of Cadherin-Based Adhesion Molecules in Cutaneous Malignant Melanoma
Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 949 - 958.
[Abstract] [Full Text] [PDF]


Home page
Am Soc Clin Oncol Ed BookHome page
T. F. Gajewski, E. A. Grimm, B. J. Nickoloff, and A. T. Weeraratna
New Potential Therapeutic Targets in Melanoma
ASCO Educational Book, January 1, 2008; 2008(1): 404 - 407.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K. Gravdal, O. J. Halvorsen, S. A. Haukaas, and L. A. Akslen
A Switch from E-Cadherin to N-Cadherin Expression Indicates Epithelial to Mesenchymal Transition and Is of Strong and Independent Importance for the Progress of Prostate Cancer
Clin. Cancer Res., December 1, 2007; 13(23): 7003 - 7011.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. D. McCall, N. Harii, C. J. Lewis, R. Malgor, W. Bae Kim, M. Saji, A. D. Kohn, R. T. Moon, and L. D. Kohn
High Basal Levels of Functional Toll-Like Receptor 3 (TLR3) and Noncanonical Wnt5a Are Expressed in Papillary Thyroid Cancer and Are Coordinately Decreased by Phenylmethimazole Together with Cell Proliferation and Migration
Endocrinology, September 1, 2007; 148(9): 4226 - 4237.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.